Abstract

USRDS studies provide results that are consistent when considering the effect of time since the onset of ESRD in comparisons of PD and HD outcomes. The results are representative of patient selection and practice in the U.S., but may not apply in other countries, where patients are selected to PD using very different criteria. In international comparisons, even adjustment for comorbid conditions may not fully compensate for selection. The analytical experience from the USRDS may serve as a model for similar analyses in environments where different practices and registries are used.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.